Cross-Sector entity
Weiss Ratings is the most frequent co-covered peer, appearing in 6 of the 7 tracked stories. Across a 187-day span, the pace is roughly 0.3 stories per week. The busiest single day carried 3. markets accounts for 4 of the 7 tracked stories, while 3 other categories carry the remainder.
7 verified stories tracked
Last mentioned: 1d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Weiss Ratings is the most frequent co-covered peer, appearing in 6 of the 7 tracked stories. Across a 187-day span, the pace is roughly 0.3 stories per week. The busiest single day carried 3. markets accounts for 4 of the 7 tracked stories, while 3 other categories carry the remainder. This profile follows 7 Cross-Sector stories mentioning Raymond James Financial across the period from February 19, 2026 to August 24, 2026. The tracked stories average 2.3 original sources each. 0% of these stories carry negative sentiment.
Computed from the 7 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Raymond James Financial. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen issues opposing ratings
Downgraded T1 Energy from Sell to Strong Sell and upgraded SM Energy from Buy to Strong Buy.
T1 Energy earnings and BTIG target move
T1 Energy reported a -$0.09 EPS loss; BTIG raised its T1 target from $8.00 to $9.00 with a Buy rating.
Truist raises SM Energy target
Increased price target from $37.00 to $43.00 and maintained a Buy rating.
SM Energy quarterly results
SM Energy reported $2.19 earnings per share for the quarter.
Two updates on SM Energy
Susquehanna lifted its SM target from $31 to $32 (Neutral); Raymond James lowered its target from $55 to $48 (Outperform).
UBS initiates SM Energy
Started coverage with a Buy rating and a $36.00 target price.
Weiss Ratings reaffirms T1 Energy sell
Reaffirmed a Sell (D-) rating on T1 Energy.
Bernstein assumes T1 Energy coverage
Set a Market Perform rating and a $9.00 price objective.
Northland Securities initiates T1 Energy
Started coverage with an Outperform rating and a $16.00 price objective.
Zacks Research upgrades T1 Energy
Moved T1 Energy from Strong Sell to Hold.
Siebert Williams Shank upgrades SM Energy
Raised SM Energy from Hold to Buy and lifted target price from $30.00 to $41.00.
Wall Street Zen issued divergent ratings on two energy names, cutting T1 Energy to Strong Sell while lifting SM Energy to Strong Buy. T1 trades at $4.45 with negative P/E and 3.5 D/E, while SM offers a 7.35 P/E and 0.85 D/E. The split highlights a rotation from leveraged loss-makers to cash-flow-positive mid-cap energy.
Source: themarketsdaily.com · dailypolitical.com
A Q2 13F filing shows Northwestern Mutual Wealth Management initiated a $106.97M RTX position and an $18.25M Cummins stake. Analysts are raising price targets on both names, reinforcing institutional conviction in industrial cyclicals.
Source: Watch List News · Bbns
Construction Partners (ROAD) posted a $0.07 EPS surprise and 28.2% revenue growth, yet analyst downgrades and price target cuts cloud the outlook. The stock's low PEG ratio of 0.85 contrasts with a high debt load and thin margins, creating a complex picture for value and growth investors.
Source: themarketsdaily.com · dailypolitical.com
Wall Street Zen downgraded vaccine maker Novavax to sell, raising alarms in the healthcare sector. The stock traded at $7.41, far below its $13 consensus target, with a negative P/E of -12.78.
In a single day, Wall Street Zen downgraded CME Group to strong sell, and Novavax and SNDL to sell, sending bearish signals across exchanges, biotech, and cannabis. Markets digest the calls amid wide analyst disagreement.
Novavax was slapped with a sell rating by Wall Street Zen, even after beating Q1 revenue estimates by 49%. The downgrade highlights biotech skepticism toward small-cap vaccine players in a shifting market.
Source: dailypolitical.com · tickerreport.com
Analyst sentiment remains a critical barometer for Principal Financial, Raymond James, Cooper Companies, and Elevance Health as they navigate sector-specific headwinds. While wealth management and retirement services show resilience, the healthcare and medical device sectors face evolving regulatory and utilization challenges.
Source: finance.yahoo.com · finance.yahoo.com
